IMA Q4 2024 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$5M

Operating Income

-$13M

Net Income

-$9M

EPS (Diluted)

$-0.19

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$998,000

Balance Sheet

Total Assets

$142M

Total Liabilities

$16M

Stockholders' Equity

$126M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$659,000	-100.0%
Gross Profit	-$5M	$354,000	-1393.8%
Operating Income	-$13M	-$22M	+42.9%
Net Income	-$9M	-$19M	+53.2%